Bioglyco ApS: Financial statements 2025
CVR: 39676664
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
Bioglyco ApS (CVR 39676664) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -3,750 and a net result of DKK -3,750 compared with DKK -2,625 the year before. Equity in the 2025 report amounted to DKK 17,692. The solvency ratio was 48.3%.
- Gross Profit
- DKK -3,750
- Profit/Loss
- DKK -3,750
- Equity
- DKK 17,692
- Total Assets
- DKK 36,648
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -4 t. | -4 t. | 18 t. | 0 |
| 2024 | - | -3 t. | -3 t. | 21 t. | 0 |
| 2023 | - | -3 t. | -3 t. | 24 t. | - |
| 2022 | - | -2 t. | -2 t. | 27 t. | - |
| 2021 | - | -2 t. | -2 t. | 4 t. | - |
Official annual report
How creditworthy is Bioglyco ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout Bioglyco ApS
Bioglyco ApS is a Danish company of the type Anpartsselskab based in Odense SØ, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named Bioglyco IVS. The management consists of Giuseppe Palmisano. The company is owned by Giuseppe Palmisano. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -3,750 and a net result of DKK -3,750 compared with DKK -2,625 the year before. Equity in the 2025 report amounted to DKK 17,692.